JLS Fund logo

JLS Fund

North America, New York, United States, New York

Description

JLS Fund is a venture capital firm that invests in the psychedelics and technology intersection.

Investor Profile

JLS Fund has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Seed (43%)
  • Series A (29%)
  • Series B (14%)
  • Post Ipo Equity (14%)

Country Focus

  • United States (86%)
  • Canada (14%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Gaming
  • Mental Health
  • Personal Health
  • Virtual Reality
  • Wellness
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does JLS Fund frequently co-invest with?

Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2
Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 2
NK
Europe, England, United Kingdom, London
Co-Investments: 2
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 3
Prime Movers Lab
North America, Wyoming, United States, Jackson
Co-Investments: 2
GV
North America, California, United States, Newport Beach
Co-Investments: 2
PS
North America, Illinois, United States, Highland Park
Co-Investments: 2
Iter Investments
North America, Florida, United States, Fort Lauderdale
Co-Investments: 2
Route 66 Ventures
North America, Virginia, United States, Alexandria
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2

Which angels does JLS Fund often collaborate with?

MM
North America, Texas, United States, Houston
Shared Deals: 1
SB
North America, California, United States
Shared Deals: 1
David Fraga
North America, New York, United States, New York
Shared Deals: 1
GS
North America, Indiana, United States, Indianapolis
Shared Deals: 1
SF
North America, Connecticut, United States, New Haven
Shared Deals: 1
MC
North America, New York, United States
Shared Deals: 1
JH
North America, California, United States
Shared Deals: 1
RG
North America, Nevada, United States, Crystal Bay
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by JLS Fund?

Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BDec 15, 2022
Amount Raised: $39,000,000
Homecoming

Toronto, Ontario, Canada

Homecoming is a provider of patient engagement tools for psychedelic therapy.

Health CareMedical
SeedApr 7, 2022
Amount Raised: $4,000,000
Fluence

New York, New York, United States

Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy.

Continuing EducationE-LearningEducationPsychologyTraining
SeedNov 4, 2021
Amount Raised: $1,600,000
Psilera

Tampa, Florida, United States

Psilera is delivering next-generation psychedelics at home using a platform approach to derisk and scale the drug discovery & design process

BiotechnologyLife SciencePharmaceutical
SeedJul 1, 2021
Amount Raised: $2,500,000
TRIPP

Los Angeles, California, United States

TRIPP is a digital psychedelic wellness platform that uses virtual and augmented reality focusing on mental health.

GamingMental HealthPersonal HealthVirtual RealityWellness
Series AJun 25, 2021
Amount Raised: $11,000,000
Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series AMay 6, 2021
Amount Raised: $27,000,000
WeSana Health

Homer Glen, Illinois, United States

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine.

Alternative MedicineHealth CareTherapeutics
Post Ipo EquityMar 31, 2021
Amount Raised: $12,813,472